获取演示
Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
Rapt

六月 2026

六月 2026的Rapt市场份额分析

RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by our mission to treat inflammatory and immunologic diseases. Our cutting-edge science is fully focused on developing therapeutics that intelligently target key drivers of the immune system to transform the treatment of inflammatory and immunologic diseases, and improve and empower countless lives. Join us in our quest.
成立年份2015
员工51 - 200
年营收$2M - $5M
rapt.com
Rapt
Rapt(包含公司地区分支机构)
  • rapt.com
    rapt.com
查看更多网站流量和参与度信息

Rapt收入截至 六月 2026为 2M - 5M

Rapt主要域名产生的收入

3 年中Rapt主要域名的收入

Rapt主要域名的收入


Rapt热门域名的总访问量

了解Rapt市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

Rapt热门域名的平均访问时长

分析Rapt参与度指标。

过去 3 个月的平均访问时长

子公司明细

Rapt热门域名的平均页面浏览量

了解Rapt如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

想要获取更深入的流量洞见?

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。



Rapt 采用的主要技术

这些是排名前 Rapt 的顶级域名所使用的网站技术(按行业分列)

付费广告 (4)

DoubleClick

DoubleClick

小部件 (3)

视听媒体 (2)

内容管理系统 (2)

WordPress

WordPress

更多技术

6

查看全部

准备好发现优质潜在客户了吗?

借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。


Rapt 的新闻与信号

借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。

新闻RAPT Therapeutics, Inc. is developing novel therapies for patients living with inflammatory and immunologic diseases.GSK announced that it has entered a definitive agreement to acquire RAPT Therapeutics, a California-based, clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients living with inflammatory and immunologic diseases.
新闻GlaxoSmithKline is planning to acquire RAPT Therapeutics, Inc. for $2.2B.British pharmaceutical company GSK has signed a definitive agreement to acquire US biotech company Rapt Therapeutics for USD 58 per share, representing a total value of USD 2.2bn, announces GSK on Tuesday before the market opened.
新闻RAPT Therapeutics, Inc. attends event 44th Annual J.P. Morgan Healthcare Conference.SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) - RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific Time.

查看 Rapt 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。